Institutional Access, Deep Research & Advanced Investor insights.
OTC Stock Lookup
Featured research
OTC Leads score
91
A new North American fintech platform, exclusive perpetual licenses, and a deeply compressed chart define the setup. Execution is the next chapter.
Setup
Bottom Watch — Speculative
Published
Fintech / Prediction Markets
The CEO of Winners Inc. (OTC: WNRS) on the Reg A+ raise, the MeVu prediction market aggregator, AI agent swarms, and the path to OTCQX uplisting.
Lead analysis
High-conviction reports with the clearest near-term catalysts.
As MAJI targets strategic share retirement, the planned LMMY distribution creates a rare dual-catalyst setup for existing shareholders.
Four operational pillars, documented filings, and a measured catalyst matrix for Tiderock Companies.
Market signals
Strategic and technical reads across active OTC names.
AI-powered prediction markets, Reg A+ raise, and the path to OTCQX uplisting.
Rare disease pipeline with orphan drug designation and near-term catalyst potential.
Momentum breakout setup with strong accumulation signals and HIV pipeline optionality.
Company spotlights
Focused coverage on emerging commercial opportunities.
NexTel Medical enters the $1.2B veterinary oncology market with a differentiated platform targeting companion animal cancer treatment.
The commercial launch of Maxasome marks MAJI's transition from development-stage to revenue-generating biotech platform.
Research archive
Additional analysis from the OTC Leads desk.
Membership
Membership is selective — we vet every applicant to ensure signal, not noise. Applications are reviewed within 48 hours.
